Clinical Trials Directory

Trials / Completed

CompletedNCT05476978

Artificial Intelligence in EUS for Diagnosing Pancreatic Solid Lesions

Utilization of Artificial Intelligence for the Development of an EUS-convolution Neural Network Model Trained to Differentiate Pancreatic Cancer From Other Pancreatic Solid Lesions

Status
Completed
Phase
Study type
Observational
Enrollment
130 (actual)
Sponsor
Huazhong University of Science and Technology · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

We aim to develop an EUS-AI model which can facilitate clinical diagnosis by analyzing EUS pictures and clinical parameters of patients.

Detailed description

EUS is considered to be a more sensitive modality than CT in detecting pancreatic solid lesions due to its high spatial resolution. However, the diagnostic performance is largely dependent on the experience and the technical abilities of the practitioners. Therefore, we aim to develop an objective EUS diagnostic model based on the convolutional neural network, an artificial intelligence technique. In addition, clinical parameters such as risk factors, tumor biomarkers and radiology findings are also added to this artificial intelligence model in order to mimic the actual clinical diagnosis procedures and to increase the performance of this model.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEUS-AI modelThe test subset (approximately 20% of total patients) is reserved for the final evaluation of the EUS-AI model. Clinical parameters and EUS pictures of each patient in the test subset will be inputed into the trained EUS-AI model, and the most possible diagnosis will be given by the model.

Timeline

Start date
2022-07-01
Primary completion
2023-06-30
Completion
2024-01-24
First posted
2022-07-27
Last updated
2024-04-03

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05476978. Inclusion in this directory is not an endorsement.